NEWS

The global picture of AI in the biomanufacturing industry

6 July 2023
Information Technology
Isabelle Lequeux
Program Manager – Regulatory Lead

In May 2023, the FDA published a discussion paper on Artificial Intelligence in Drug Manufacturing, inviting industry feedback and comment. This paper is critical for BioPhorum members as it captures some of the most innovative ways of working, they aim to implement globally.

Our responses have now been published in Industry feedback on artificial intelligence in drug manufacturing: FDA discussion paper.

The FDA offered eight questions against which industry was to provide its feedback, including:

  1. What types of AI applications do you envision being used in pharmaceutical manufacturing?
  2. What are the necessary elements for a manufacturer to implement AI-based models in a cGMP environment?
  3. What are the necessary mechanisms for managing the data used to generate AI models in pharmaceutical manufacturing?

BioPhorum members – both technical and regulatory subject matter experts – were brought together by the Regulatory Governance and External Partnerships team (REGx) to provide the FDA with their views on the current state of implementation of AI in industry. They also discussed their technical and regulatory challenges and their ultimate goal: the real-time release of products in a fully automated plant.

In June 2022, BioPhorum had already identified one of the most challenging topics associated with AI: data integrity for analytical methods that rely on AI for data interpretation, such as next-generation sequencing. This was brought to the FDA’s attention and is a great demonstration of BioPhorum’s forward thinking to see this specific topic addressed in the discussion paper.

As well as providing detailed feedback to the FDA, our paper also presents a global picture of the current state of the biomanufacturing industry on the implementation of AI. It can be used by subject matter experts, business leaders, and key opinion makers to assess their current AI maturity level compared to others and potentially identify future areas of collaboration.

For more information, download the paper here and contact Isabelle Lequeux, Program Manager – Regulatory Lead, at isabelle.lequeux@biophorum.com

NEWS
A major milestone – a harmonized approach to product carbon footprint data
NEWS
Combination products – MediPhorum’s ‘state of the nation’ report
NEWS
Inaugural BioPhorum Quality face to face – get involved
NEWS
Forecasting the demand for single-use systems
NEWS
The new Drug Substance Strategic Value Framework – addressing industry pain points

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing